The application of dynamic contrast-enhanced ultrasonography in immediate distinguishing residual tumour from benign periablational enhancement after hepatocellular carcinoma radiofrequency ablation
Medical Ultrasonography · 2024
DOI: 10.11152/mu-4394 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Ultrasonography, 2024. Verfasst von Yue Ma und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Ultrasound, The First Affiliated Hospital of the Bengbu Medical College, Bengbu, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Contrast Media, Neoplasm, Residual.
Abstract (Originalsprache)
Aim
This study set out to access the performance of quantitative analysis of contrast-enhanced ultrasound (CEUS) in distinguishing between benign periablational enhancement (BPE) and residual tumor (RT) following radiofrequency ablation (RFA).Materials and methods: 165 tumors from 124 patients with hepatocellular carcinoma between 2021 and 2023 underwent RFA, contrast-enhanced computed tomography (CECT), and CEUS in less than 24 hours. Analysis was done on the quantitative parameters from RT and BPE found by CEUS.
Results
Complete ablation was obtained in 89.1% of lesions. When compared to BPE, RT had significantly greater peak intensity (PI), time to peak (TTP), area under the curve (AUC), ratio of PI and base intensity (PI/BI), and enhanced intensity (EI) values (all p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Ultrasound, The First Affiliated Hospital of the Bengbu Medical College, Bengbu, China.
- Department of Medical Ultrasound, The First Affiliated Hospital of the Bengbu Medical College, Bengbu, China. onlyworld_2012@126.com.
- School of Medical Imaging, Bengbu Medical University, Bengbu, China.
- Department of Clinical and Research, Shenzhen Mindray Bio-medical Electronics Company Limited, Shenzhen, China.
Zitieren
APA
Ma, Y., Li, Y., Zhu, M., Wang, S. Y., Yang, F. R., Xu, Y. Q., Yang, R., Wu, B. B., & Sun, Y. X. (2024). The application of dynamic contrast-enhanced ultrasonography in immediate distinguishing residual tumour from benign periablational enhancement after hepatocellular carcinoma radiofrequency ablation. Medical Ultrasonography. https://doi.org/10.11152/mu-4394
Vancouver
Ma Y, Li Y, Zhu M, Wang SY, Yang FR, Xu YQ, et al. The application of dynamic contrast-enhanced ultrasonography in immediate distinguishing residual tumour from benign periablational enhancement after hepatocellular carcinoma radiofrequency ablation. Medical Ultrasonography. 2024. doi:10.11152/mu-4394
BibTeX
@article{Ma2024,
author = {Ma, Yue and Li, Yang and Zhu, Min and Wang, Shi-Yu and Yang, Feng-Rong and Xu, Yu-Qing and Yang, Ru and Wu, Ban-Ban and Sun, Yi-Xue},
title = {The application of dynamic contrast-enhanced ultrasonography in immediate distinguishing residual tumour from benign periablational enhancement after hepatocellular carcinoma radiofrequency ablation},
journal = {Medical Ultrasonography},
year = {2024},
doi = {10.11152/mu-4394}
}
EUVIMED